| HGNC Family | Cadherins |
| Name | protocadherin gamma subfamily A, 11 |
| Description | This gene is a member of the protocadherin gamma gene cluster, one of three related clusters tandemly linked on chromosome five. These gene clusters have an immunoglobulin-like organization, suggesting that a novel mechanism may be involved in their regulation and expression. The gamma gene cluster includes 22 genes divided into 3 subfamilies. Subfamily A contains 12 genes, subfamily B contains 7 genes and 2 pseudogenes, and the more distantly related subfamily C contains 3 genes. The tandem array of 22 large, variable region exons are followed by a constant region, containing 3 exons shared by all genes in the cluster. Each variable region exon encodes the extracellular region, which includes 6 cadherin ectodomains and a transmembrane region. The constant region exons encode the common cytoplasmic region. These neural cadherin-like cell adhesion proteins most likely play a critical role in the establishment and function of specific cell-cell connections in the brain. Alternative splicing has been described for the gamma cluster genes. [provided by RefSeq, Jul 2008] |
| Summary |
{"type": "root", "children": [{"type": "p", "children": [{"type": "t", "text": "\nThe collection of abstracts provided focuses almost exclusively on tau protein–related mechanisms in Alzheimer’s disease and other tauopathies—including tau phosphorylation, aggregation, fragmentation, clearance, and trans‐cellular propagation—and on the interplay between tau, amyloid‐β, and other modulators of neuronal toxicity. Notably, none of these studies mention or investigate any function for PCDHGA11."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "1", "end_ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nA wide array of experimental approaches is used in these reports—from transgenic animal models and neuronal culture systems to cutting‐edge proteomic and imaging techniques—to elucidate the complex contributions of tau to synaptic dysfunction, mitochondrial impairment, aberrant intracellular signaling (e.g., through kinases such as GSK3β, Cdk5, and p38), and even the involvement of inflammatory processes and sleep–wake cycle influences. In each case, however, emphasis is placed on understanding the pathophysiological cascades driven by tau and amyloid‑β, with no reference to cell adhesion molecules or protocadherin family members such as PCDHGA11."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "12", "end_ref": "21"}]}, {"type": "t", "text": "\n"}]}, {"type": "t", "text": "\n\n"}, {"type": "p", "children": [{"type": "t", "text": "\nIn summary, while these studies contribute substantially to our understanding of neurodegenerative processes, particularly regarding tau’s deleterious roles in Alzheimer’s disease and its propagation throughout neural networks, they do not address any aspect of PCDHGA11 function. Thus, based on the current literature summarized here, no insight into the role or mechanism of PCDHGA11 in the brain is available, and further dedicated research will be necessary to determine whether this protocadherin has relevance to tau‐related pathology or other neurodegenerative events."}, {"type": "fg", "children": [{"type": "fg_fs", "start_ref": "22", "end_ref": "35"}, {"type": "fg_f", "ref": "11"}]}, {"type": "t", "text": "\n"}]}, {"type": "rg", "children": [{"type": "r", "ref": 1, "children": [{"type": "t", "text": "Mark Rapoport, Hana N Dawson, Lester I Binder, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tau is essential to beta -amyloid-induced neurotoxicity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2002)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.092136199"}], "href": "https://doi.org/10.1073/pnas.092136199"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "11959919"}], "href": "https://pubmed.ncbi.nlm.nih.gov/11959919"}]}, {"type": "r", "ref": 2, "children": [{"type": "t", "text": "Della C David, Susanne Hauptmann, Isabel Scherping, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Proteomic and functional analyses reveal a mitochondrial dysfunction in P301L tau transgenic mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M500356200"}], "href": "https://doi.org/10.1074/jbc.M500356200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "15831501"}], "href": "https://pubmed.ncbi.nlm.nih.gov/15831501"}]}, {"type": "r", "ref": 3, "children": [{"type": "t", "text": "Kiran Bhaskar, Shu-Hui Yen, Gloria Lee "}, {"type": "b", "children": [{"type": "t", "text": "Disease-related modifications in tau affect the interaction between Fyn and Tau."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2005)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M505895200"}], "href": "https://doi.org/10.1074/jbc.M505895200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16115884"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16115884"}]}, {"type": "r", "ref": 4, "children": [{"type": "t", "text": "Florian Plattner, Marco Angelo, K Peter Giese "}, {"type": "b", "children": [{"type": "t", "text": "The roles of cyclin-dependent kinase 5 and glycogen synthase kinase 3 in tau hyperphosphorylation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M603469200"}], "href": "https://doi.org/10.1074/jbc.M603469200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "16803897"}], "href": "https://pubmed.ncbi.nlm.nih.gov/16803897"}]}, {"type": "r", "ref": 5, "children": [{"type": "t", "text": "Salvatore Oddo, Vitaly Vasilevko, Antonella Caccamo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Reduction of soluble Abeta and tau, but not soluble Abeta alone, ameliorates cognitive decline in transgenic mice with plaques and tangles."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2006)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M608485200"}], "href": "https://doi.org/10.1074/jbc.M608485200"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17056594"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17056594"}]}, {"type": "r", "ref": 6, "children": [{"type": "t", "text": "Hong-Lian Li, Hai-Hong Wang, Shi-Jie Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Phosphorylation of tau antagonizes apoptosis by stabilizing beta-catenin, a mechanism involved in Alzheimer's neurodegeneration."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0609303104"}], "href": "https://doi.org/10.1073/pnas.0609303104"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17360687"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17360687"}]}, {"type": "r", "ref": 7, "children": [{"type": "t", "text": "Simon Melov, Paul A Adlard, Karl Morten, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Mitochondrial oxidative stress causes hyperphosphorylation of tau."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2007)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0000536"}], "href": "https://doi.org/10.1371/journal.pone.0000536"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "17579710"}], "href": "https://pubmed.ncbi.nlm.nih.gov/17579710"}]}, {"type": "r", "ref": 8, "children": [{"type": "t", "text": "Chiho Hirata-Fukae, Hui-Fang Li, Hyang-Sook Hoe, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Females exhibit more extensive amyloid, but not tau, pathology in an Alzheimer transgenic model."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Brain Res (2008)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.brainres.2008.03.079"}], "href": "https://doi.org/10.1016/j.brainres.2008.03.079"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "18486110"}], "href": "https://pubmed.ncbi.nlm.nih.gov/18486110"}]}, {"type": "r", "ref": 9, "children": [{"type": "t", "text": "Bhumsoo Kim, Carey Backus, Sangsu Oh, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Increased tau phosphorylation and cleavage in mouse models of type 1 and type 2 diabetes."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Endocrinology (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1210/en.2009-0695"}], "href": "https://doi.org/10.1210/en.2009-0695"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19819959"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19819959"}]}, {"type": "r", "ref": 10, "children": [{"type": "t", "text": "Virginie Rhein, Xiaomin Song, Andreas Wiesner, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Amyloid-beta and tau synergistically impair the oxidative phosphorylation system in triple transgenic Alzheimer's disease mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0905529106"}], "href": "https://doi.org/10.1073/pnas.0905529106"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19897719"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19897719"}]}, {"type": "r", "ref": 11, "children": [{"type": "t", "text": "Yazi D Ke, Fabien Delerue, Amadeus Gladbach, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Experimental diabetes mellitus exacerbates tau pathology in a transgenic mouse model of Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2009)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0007917"}], "href": "https://doi.org/10.1371/journal.pone.0007917"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "19936237"}], "href": "https://pubmed.ncbi.nlm.nih.gov/19936237"}]}, {"type": "r", "ref": 12, "children": [{"type": "t", "text": "Lars M Ittner, Yazi D Ke, Fabien Delerue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer's disease mouse models."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.cell.2010.06.036"}], "href": "https://doi.org/10.1016/j.cell.2010.06.036"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20655099"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20655099"}]}, {"type": "r", "ref": 13, "children": [{"type": "t", "text": "Keith A Vossel, Kai Zhang, Jens Brodbeck, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tau reduction prevents Abeta-induced defects in axonal transport."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.1194653"}], "href": "https://doi.org/10.1126/science.1194653"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "20829454"}], "href": "https://pubmed.ncbi.nlm.nih.gov/20829454"}]}, {"type": "r", "ref": 14, "children": [{"type": "t", "text": "Eva Kickstein, Sybille Krauss, Paul Thornhill, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Biguanide metformin acts on tau phosphorylation via mTOR/protein phosphatase 2A (PP2A) signaling."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2010)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.0912793107"}], "href": "https://doi.org/10.1073/pnas.0912793107"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21098287"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21098287"}]}, {"type": "r", "ref": 15, "children": [{"type": "t", "text": "Audrey Sultan, Fabrice Nesslany, Marie Violet, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Nuclear tau, a key player in neuronal DNA protection."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M110.199976"}], "href": "https://doi.org/10.1074/jbc.M110.199976"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21131359"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21131359"}]}, {"type": "r", "ref": 16, "children": [{"type": "t", "text": "Erik D Roberson, Brian Halabisky, Jong W Yoo, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Amyloid-β/Fyn-induced synaptic, network, and cognitive impairments depend on tau levels in multiple mouse models of Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.4152-10.2011"}], "href": "https://doi.org/10.1523/JNEUROSCI.4152-10.2011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21228179"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21228179"}]}, {"type": "r", "ref": 17, "children": [{"type": "t", "text": "Olivia A Shipton, Julie R Leitz, Jenny Dworzak, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tau protein is required for amyloid {beta}-induced impairment of hippocampal long-term potentiation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.2610-10.2011"}], "href": "https://doi.org/10.1523/JNEUROSCI.2610-10.2011"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21289177"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21289177"}]}, {"type": "r", "ref": 18, "children": [{"type": "t", "text": "Hiroki Takeuchi, Michiyo Iba, Haruhisa Inoue, et al. "}, {"type": "b", "children": [{"type": "t", "text": "P301S mutant human tau transgenic mice manifest early symptoms of human tauopathies with dementia and altered sensorimotor gating."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "PLoS One (2011)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1371/journal.pone.0021050"}], "href": "https://doi.org/10.1371/journal.pone.0021050"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "21698260"}], "href": "https://pubmed.ncbi.nlm.nih.gov/21698260"}]}, {"type": "r", "ref": 19, "children": [{"type": "t", "text": "Jerrah K Holth, Valerie C Bomben, J Graham Reed, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Tau loss attenuates neuronal network hyperexcitability in mouse and Drosophila genetic models of epilepsy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Neurosci (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1523/JNEUROSCI.3191-12.2013"}], "href": "https://doi.org/10.1523/JNEUROSCI.3191-12.2013"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23345237"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23345237"}]}, {"type": "r", "ref": 20, "children": [{"type": "t", "text": "Antonella Caccamo, Andrea Magrì, David X Medina, et al. "}, {"type": "b", "children": [{"type": "t", "text": "mTOR regulates tau phosphorylation and degradation: implications for Alzheimer's disease and other tauopathies."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Aging Cell (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1111/acel.12057"}], "href": "https://doi.org/10.1111/acel.12057"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23425014"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23425014"}]}, {"type": "r", "ref": 21, "children": [{"type": "t", "text": "Luis F Maia, Stephan A Kaeser, Julia Reichwald, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Changes in amyloid-β and Tau in the cerebrospinal fluid of transgenic mice overexpressing amyloid precursor protein."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Transl Med (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/scitranslmed.3006446"}], "href": "https://doi.org/10.1126/scitranslmed.3006446"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "23863834"}], "href": "https://pubmed.ncbi.nlm.nih.gov/23863834"}]}, {"type": "r", "ref": 22, "children": [{"type": "t", "text": "Erin E Congdon, Jiaping Gu, Hameetha B R Sait, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antibody uptake into neurons occurs primarily via clathrin-dependent Fcγ receptor endocytosis and is a prerequisite for acute tau protein clearance."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Biol Chem (2013)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1074/jbc.M113.491001"}], "href": "https://doi.org/10.1074/jbc.M113.491001"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24163366"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24163366"}]}, {"type": "r", "ref": 23, "children": [{"type": "t", "text": "Kaoru Yamada, Jerrah K Holth, Fan Liao, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Neuronal activity regulates extracellular tau in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20131685"}], "href": "https://doi.org/10.1084/jem.20131685"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "24534188"}], "href": "https://pubmed.ncbi.nlm.nih.gov/24534188"}]}, {"type": "r", "ref": 24, "children": [{"type": "t", "text": "Brandon B Holmes, Jennifer L Furman, Thomas E Mahan, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Proteopathic tau seeding predicts tauopathy in vivo."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Proc Natl Acad Sci U S A (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1073/pnas.1411649111"}], "href": "https://doi.org/10.1073/pnas.1411649111"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25261551"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25261551"}]}, {"type": "r", "ref": 25, "children": [{"type": "t", "text": "Zhentao Zhang, Mingke Song, Xia Liu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Med (2014)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nm.3700"}], "href": "https://doi.org/10.1038/nm.3700"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "25326800"}], "href": "https://pubmed.ncbi.nlm.nih.gov/25326800"}]}, {"type": "r", "ref": 26, "children": [{"type": "t", "text": "Wenjie Luo, Wencheng Liu, Xiaoyan Hu, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Microglial internalization and degradation of pathological tau is enhanced by an anti-tau monoclonal antibody."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Sci Rep (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/srep11161"}], "href": "https://doi.org/10.1038/srep11161"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26057852"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26057852"}]}, {"type": "r", "ref": 27, "children": [{"type": "t", "text": "Asami Kondo, Koorosh Shahpasand, Rebekah Mannix, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Antibody against early driver of neurodegeneration cis P-tau blocks brain injury and tauopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature14658"}], "href": "https://doi.org/10.1038/nature14658"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26176913"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26176913"}]}, {"type": "r", "ref": 28, "children": [{"type": "t", "text": "Hirohide Asai, Seiko Ikezu, Satoshi Tsunoda, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Depletion of microglia and inhibition of exosome synthesis halt tau propagation."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nat Neurosci (2015)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nn.4132"}], "href": "https://doi.org/10.1038/nn.4132"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "26436904"}], "href": "https://pubmed.ncbi.nlm.nih.gov/26436904"}]}, {"type": "r", "ref": 29, "children": [{"type": "t", "text": "Tara Vanderweyde, Daniel J Apicco, Katherine Youmans-Kidder, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Interaction of tau with the RNA-Binding Protein TIA1 Regulates tau Pathophysiology and Toxicity."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Cell Rep (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.celrep.2016.04.045"}], "href": "https://doi.org/10.1016/j.celrep.2016.04.045"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27160897"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27160897"}]}, {"type": "r", "ref": 30, "children": [{"type": "t", "text": "Min Shi, Andrej Kovac, Ane Korff, et al. "}, {"type": "b", "children": [{"type": "t", "text": "CNS tau efflux via exosomes is likely increased in Parkinson's disease but not in Alzheimer's disease."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Alzheimers Dement (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1016/j.jalz.2016.04.003"}], "href": "https://doi.org/10.1016/j.jalz.2016.04.003"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27234211"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27234211"}]}, {"type": "r", "ref": 31, "children": [{"type": "t", "text": "Jing L Guo, Sneha Narasimhan, Lakshmi Changolkar, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Unique pathological tau conformers from Alzheimer's brains transmit tau pathology in nontransgenic mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20160833"}], "href": "https://doi.org/10.1084/jem.20160833"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27810929"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27810929"}]}, {"type": "r", "ref": 32, "children": [{"type": "t", "text": "Arne Ittner, Sook Wern Chua, Josefine Bertz, et al. "}, {"type": "b", "children": [{"type": "t", "text": "Site-specific phosphorylation of tau inhibits amyloid-β toxicity in Alzheimer's mice."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2016)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.aah6205"}], "href": "https://doi.org/10.1126/science.aah6205"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "27856911"}], "href": "https://pubmed.ncbi.nlm.nih.gov/27856911"}]}, {"type": "r", "ref": 33, "children": [{"type": "t", "text": "Yang Shi, Kaoru Yamada, Shane Antony Liddelow, et al. "}, {"type": "b", "children": [{"type": "t", "text": "ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Nature (2017)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1038/nature24016"}], "href": "https://doi.org/10.1038/nature24016"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "28959956"}], "href": "https://pubmed.ncbi.nlm.nih.gov/28959956"}]}, {"type": "r", "ref": 34, "children": [{"type": "t", "text": "Heidi Martini-Stoica, Allysa L Cole, Daniel B Swartzlander, et al. "}, {"type": "b", "children": [{"type": "t", "text": "TFEB enhances astroglial uptake of extracellular tau species and reduces tau spreading."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "J Exp Med (2018)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1084/jem.20172158"}], "href": "https://doi.org/10.1084/jem.20172158"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30108137"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30108137"}]}, {"type": "r", "ref": 35, "children": [{"type": "t", "text": "Jerrah K Holth, Sarah K Fritschi, Chanung Wang, et al. "}, {"type": "b", "children": [{"type": "t", "text": "The sleep-wake cycle regulates brain interstitial fluid tau in mice and CSF tau in humans."}]}, {"type": "t", "text": " "}, {"type": "i", "children": [{"type": "t", "text": "Science (2019)"}]}, {"type": "t", "text": " DOI: "}, {"type": "a", "children": [{"type": "t", "text": "10.1126/science.aav2546"}], "href": "https://doi.org/10.1126/science.aav2546"}, {"type": "t", "text": " PMID: "}, {"type": "a", "children": [{"type": "t", "text": "30679382"}], "href": "https://pubmed.ncbi.nlm.nih.gov/30679382"}]}]}]}
|
| Synonyms | PCDH-GAMMA-A11 |
| Proteins | PCDGB_HUMAN |
| NCBI Gene ID | 56105 |
| API | |
| Download Associations | |
| Predicted Functions |
![]() |
| Co-expressed Genes |
![]() |
| Expression in Tissues and Cell Lines |
![]() |
PCDHGA11 has 3,484 functional associations with biological entities spanning 8 categories (molecular profile, organism, chemical, functional term, phrase or reference, disease, phenotype or trait, structural feature, cell line, cell type or tissue, gene, protein or microRNA) extracted from 76 datasets.
Click the + buttons to view associations for PCDHGA11 from the datasets below.
If available, associations are ranked by standardized value
| Dataset | Summary | |
|---|---|---|
| Achilles Cell Line Gene Essentiality Profiles | cell lines with fitness changed by PCDHGA11 gene knockdown relative to other cell lines from the Achilles Cell Line Gene Essentiality Profiles dataset. | |
| Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles | tissues with high or low expression of PCDHGA11 gene relative to other tissues from the Allen Brain Atlas Adult Human Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles | tissues with high or low expression of PCDHGA11 gene relative to other tissues from the Allen Brain Atlas Adult Mouse Brain Tissue Gene Expression Profiles dataset. | |
| Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PCDHGA11 gene relative to other tissue samples from the Allen Brain Atlas Aging Dementia and Traumatic Brain Injury Tissue Sample Gene Expression Profiles dataset. | |
| Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq | tissue samples with high or low expression of PCDHGA11 gene relative to other tissue samples from the Allen Brain Atlas Developing Human Brain Tissue Gene Expression Profiles by RNA-seq dataset. | |
| BioGPS Cell Line Gene Expression Profiles | cell lines with high or low expression of PCDHGA11 gene relative to other cell lines from the BioGPS Cell Line Gene Expression Profiles dataset. | |
| BioGPS Human Cell Type and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PCDHGA11 gene relative to other cell types and tissues from the BioGPS Human Cell Type and Tissue Gene Expression Profiles dataset. | |
| Carcinogenome Chemical Perturbation Carcinogenicity Signatures | small molecule perturbations changing expression of PCDHGA11 gene from the Carcinogenome Chemical Perturbation Carcinogenicity Signatures dataset. | |
| CCLE Cell Line Gene CNV Profiles | cell lines with high or low copy number of PCDHGA11 gene relative to other cell lines from the CCLE Cell Line Gene CNV Profiles dataset. | |
| CCLE Cell Line Gene Expression Profiles | cell lines with high or low expression of PCDHGA11 gene relative to other cell lines from the CCLE Cell Line Gene Expression Profiles dataset. | |
| ChEA Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PCDHGA11 gene from the CHEA Transcription Factor Binding Site Profiles dataset. | |
| ChEA Transcription Factor Targets | transcription factors binding the promoter of PCDHGA11 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets dataset. | |
| ChEA Transcription Factor Targets 2022 | transcription factors binding the promoter of PCDHGA11 gene in low- or high-throughput transcription factor functional studies from the CHEA Transcription Factor Targets 2022 dataset. | |
| CMAP Signatures of Differentially Expressed Genes for Small Molecules | small molecule perturbations changing expression of PCDHGA11 gene from the CMAP Signatures of Differentially Expressed Genes for Small Molecules dataset. | |
| COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 | cellular components co-occuring with PCDHGA11 protein in abstracts of biomedical publications from the COMPARTMENTS Text-mining Protein Localization Evidence Scores 2025 dataset. | |
| COSMIC Cell Line Gene CNV Profiles | cell lines with high or low copy number of PCDHGA11 gene relative to other cell lines from the COSMIC Cell Line Gene CNV Profiles dataset. | |
| COSMIC Cell Line Gene Mutation Profiles | cell lines with PCDHGA11 gene mutations from the COSMIC Cell Line Gene Mutation Profiles dataset. | |
| CTD Gene-Chemical Interactions | chemicals interacting with PCDHGA11 gene/protein from the curated CTD Gene-Chemical Interactions dataset. | |
| CTD Gene-Disease Associations | diseases associated with PCDHGA11 gene/protein from the curated CTD Gene-Disease Associations dataset. | |
| dbGAP Gene-Trait Associations | traits associated with PCDHGA11 gene in GWAS and other genetic association datasets from the dbGAP Gene-Trait Associations dataset. | |
| DepMap CRISPR Gene Dependency | cell lines with fitness changed by PCDHGA11 gene knockdown relative to other cell lines from the DepMap CRISPR Gene Dependency dataset. | |
| DISEASES Text-mining Gene-Disease Association Evidence Scores 2025 | diseases co-occuring with PCDHGA11 gene in abstracts of biomedical publications from the DISEASES Text-mining Gene-Disease Assocation Evidence Scores 2025 dataset. | |
| DisGeNET Gene-Disease Associations | diseases associated with PCDHGA11 gene in GWAS and other genetic association datasets from the DisGeNET Gene-Disease Associations dataset. | |
| ENCODE Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PCDHGA11 gene from the ENCODE Histone Modification Site Profiles dataset. | |
| ENCODE Transcription Factor Binding Site Profiles | transcription factor binding site profiles with transcription factor binding evidence at the promoter of PCDHGA11 gene from the ENCODE Transcription Factor Binding Site Profiles dataset. | |
| ENCODE Transcription Factor Targets | transcription factors binding the promoter of PCDHGA11 gene in ChIP-seq datasets from the ENCODE Transcription Factor Targets dataset. | |
| ESCAPE Omics Signatures of Genes and Proteins for Stem Cells | PubMedIDs of publications reporting gene signatures containing PCDHGA11 from the ESCAPE Omics Signatures of Genes and Proteins for Stem Cells dataset. | |
| GAD Gene-Disease Associations | diseases associated with PCDHGA11 gene in GWAS and other genetic association datasets from the GAD Gene-Disease Associations dataset. | |
| GDSC Cell Line Gene Expression Profiles | cell lines with high or low expression of PCDHGA11 gene relative to other cell lines from the GDSC Cell Line Gene Expression Profiles dataset. | |
| GeneRIF Biological Term Annotations | biological terms co-occuring with PCDHGA11 gene in literature-supported statements describing functions of genes from the GeneRIF Biological Term Annotations dataset. | |
| GeneSigDB Published Gene Signatures | PubMedIDs of publications reporting gene signatures containing PCDHGA11 from the GeneSigDB Published Gene Signatures dataset. | |
| GEO Signatures of Differentially Expressed Genes for Diseases | disease perturbations changing expression of PCDHGA11 gene from the GEO Signatures of Differentially Expressed Genes for Diseases dataset. | |
| GEO Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PCDHGA11 gene from the GEO Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Kinase Perturbations | kinase perturbations changing expression of PCDHGA11 gene from the GEO Signatures of Differentially Expressed Genes for Kinase Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations | transcription factor perturbations changing expression of PCDHGA11 gene from the GEO Signatures of Differentially Expressed Genes for Transcription Factor Perturbations dataset. | |
| GEO Signatures of Differentially Expressed Genes for Viral Infections | virus perturbations changing expression of PCDHGA11 gene from the GEO Signatures of Differentially Expressed Genes for Viral Infections dataset. | |
| GO Biological Process Annotations 2015 | biological processes involving PCDHGA11 gene from the curated GO Biological Process Annotations 2015 dataset. | |
| GO Cellular Component Annotations 2015 | cellular components containing PCDHGA11 protein from the curated GO Cellular Component Annotations 2015 dataset. | |
| GO Molecular Function Annotations 2015 | molecular functions performed by PCDHGA11 gene from the curated GO Molecular Function Annotations 2015 dataset. | |
| GTEx Tissue Gene Expression Profiles | tissues with high or low expression of PCDHGA11 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles dataset. | |
| GTEx Tissue Gene Expression Profiles 2023 | tissues with high or low expression of PCDHGA11 gene relative to other tissues from the GTEx Tissue Gene Expression Profiles 2023 dataset. | |
| GTEx Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PCDHGA11 gene relative to other tissue samples from the GTEx Tissue Sample Gene Expression Profiles dataset. | |
| GWAS Catalog SNP-Phenotype Associations 2025 | phenotypes associated with PCDHGA11 gene in GWAS datasets from the GWAS Catalog SNP-Phenotype Associations 2025 dataset. | |
| GWASdb SNP-Disease Associations | diseases associated with PCDHGA11 gene in GWAS and other genetic association datasets from the GWASdb SNP-Disease Associations dataset. | |
| GWASdb SNP-Phenotype Associations | phenotypes associated with PCDHGA11 gene in GWAS datasets from the GWASdb SNP-Phenotype Associations dataset. | |
| HMDB Metabolites of Enzymes | interacting metabolites for PCDHGA11 protein from the curated HMDB Metabolites of Enzymes dataset. | |
| HPA Cell Line Gene Expression Profiles | cell lines with high or low expression of PCDHGA11 gene relative to other cell lines from the HPA Cell Line Gene Expression Profiles dataset. | |
| HPA Tissue Gene Expression Profiles | tissues with high or low expression of PCDHGA11 gene relative to other tissues from the HPA Tissue Gene Expression Profiles dataset. | |
| HPA Tissue Protein Expression Profiles | tissues with high or low expression of PCDHGA11 protein relative to other tissues from the HPA Tissue Protein Expression Profiles dataset. | |
| HPA Tissue Sample Gene Expression Profiles | tissue samples with high or low expression of PCDHGA11 gene relative to other tissue samples from the HPA Tissue Sample Gene Expression Profiles dataset. | |
| HPM Cell Type and Tissue Protein Expression Profiles | cell types and tissues with high or low expression of PCDHGA11 protein relative to other cell types and tissues from the HPM Cell Type and Tissue Protein Expression Profiles dataset. | |
| InterPro Predicted Protein Domain Annotations | protein domains predicted for PCDHGA11 protein from the InterPro Predicted Protein Domain Annotations dataset. | |
| JASPAR Predicted Human Transcription Factor Targets 2025 | transcription factors regulating expression of PCDHGA11 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Human Transcription Factor Targets dataset. | |
| JASPAR Predicted Mouse Transcription Factor Targets 2025 | transcription factors regulating expression of PCDHGA11 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Mouse Transcription Factor Targets 2025 dataset. | |
| JASPAR Predicted Transcription Factor Targets | transcription factors regulating expression of PCDHGA11 gene predicted using known transcription factor binding site motifs from the JASPAR Predicted Transcription Factor Targets dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles | cell lines with high or low copy number of PCDHGA11 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene CNV Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles | cell lines with high or low expression of PCDHGA11 gene relative to other cell lines from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Expression Profiles dataset. | |
| Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles | cell lines with PCDHGA11 gene mutations from the Klijn et al., Nat. Biotechnol., 2015 Cell Line Gene Mutation Profiles dataset. | |
| KnockTF Gene Expression Profiles with Transcription Factor Perturbations | transcription factor perturbations changing expression of PCDHGA11 gene from the KnockTF Gene Expression Profiles with Transcription Factor Perturbations dataset. | |
| LOCATE Curated Protein Localization Annotations | cellular components containing PCDHGA11 protein in low- or high-throughput protein localization assays from the LOCATE Curated Protein Localization Annotations dataset. | |
| LOCATE Predicted Protein Localization Annotations | cellular components predicted to contain PCDHGA11 protein from the LOCATE Predicted Protein Localization Annotations dataset. | |
| MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations | gene perturbations changing expression of PCDHGA11 gene from the MSigDB Signatures of Differentially Expressed Genes for Cancer Gene Perturbations dataset. | |
| NIBR DRUG-seq U2OS MoA Box Gene Expression Profiles | drug perturbations changing expression of PCDHGA11 gene from the NIBR DRUG-seq U2OS MoA Box dataset. | |
| PANTHER Pathways | pathways involving PCDHGA11 protein from the PANTHER Pathways dataset. | |
| Pathway Commons Protein-Protein Interactions | interacting proteins for PCDHGA11 from the Pathway Commons Protein-Protein Interactions dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations | gene perturbations changing expression of PCDHGA11 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| PerturbAtlas Signatures of Differentially Expressed Genes for Mouse Gene Perturbations | gene perturbations changing expression of PCDHGA11 gene from the PerturbAtlas Signatures of Differentially Expressed Genes for Gene Perturbations dataset. | |
| Roadmap Epigenomics Cell and Tissue Gene Expression Profiles | cell types and tissues with high or low expression of PCDHGA11 gene relative to other cell types and tissues from the Roadmap Epigenomics Cell and Tissue Gene Expression Profiles dataset. | |
| Roadmap Epigenomics Histone Modification Site Profiles | histone modification site profiles with high histone modification abundance at PCDHGA11 gene from the Roadmap Epigenomics Histone Modification Site Profiles dataset. | |
| RummaGEO Drug Perturbation Signatures | drug perturbations changing expression of PCDHGA11 gene from the RummaGEO Drug Perturbation Signatures dataset. | |
| RummaGEO Gene Perturbation Signatures | gene perturbations changing expression of PCDHGA11 gene from the RummaGEO Gene Perturbation Signatures dataset. | |
| TargetScan Predicted Conserved microRNA Targets | microRNAs regulating expression of PCDHGA11 gene predicted using conserved miRNA seed sequences from the TargetScan Predicted Conserved microRNA Targets dataset. | |
| TargetScan Predicted Nonconserved microRNA Targets | microRNAs regulating expression of PCDHGA11 gene predicted using nonconserved miRNA seed sequences from the TargetScan Predicted Nonconserved microRNA Targets dataset. | |
| TCGA Signatures of Differentially Expressed Genes for Tumors | tissue samples with high or low expression of PCDHGA11 gene relative to other tissue samples from the TCGA Signatures of Differentially Expressed Genes for Tumors dataset. | |
| TISSUES Curated Tissue Protein Expression Evidence Scores 2025 | tissues with high expression of PCDHGA11 protein from the TISSUES Curated Tissue Protein Expression Evidence Scores 2025 dataset. | |
| TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 | tissues co-occuring with PCDHGA11 protein in abstracts of biomedical publications from the TISSUES Text-mining Tissue Protein Expression Evidence Scores 2025 dataset. | |